The effect of an innovative thiadiazine-class antibacterial agent on the motility of Vibrio cholerae
Open Access
- 30 April 2026
- journal article
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 103 (2) , 229-235
Abstract
Introduction. Vibrio cholerae motility plays a key role in the pathogenesis of cholera, so finding ways to suppress it is a promising approach to combating this infection. Objective: to study the effect of Fluorothiazinone on the motility of V. cholerae. Materials and methods. Flagellar motility was determined in 0.3% agar, with the motility zone measured, in 40 strains V. cholerae El Tor of varying epidemiological significance. The ability of these strains to acquire resistance to Fluorothiazinone was also assessed through repeated subcultures on alkaline agar containing Fluorothiazinone (100 mg/L). Results. A significant decrease in the motility of all studied cultures was observed in the presence of Fluorothiazinone, without the development of resistance. Conclusion. The dose-dependent ability of Fluorothiazinone to reduce the motility of V. cholerae was demonstrated for the first time.Keywords
This publication has 32 references indexed in Scilit:
- Unraveling the 2023 cholera outbreak in Rourkela municipal corporation of Odisha, India: Antibiotic resistance, virulence factors, and water contamination insightsIndian Journal of Medical Microbiology, 2025
- Transcription Regulation of Flagellins: A Structural PerspectiveBiochemistry, 2025
- Design of novel anti-quorum sensing peptides targeting LuxO to combat Vibrio cholerae pathogenesisIn Silico Pharmacology, 2023
- A novel antivirulent compound fluorothiazinone inhibits Klebsiella pneumoniae biofilm in vitro and suppresses model pneumoniaThe Journal of Antibiotics, 2023
- Fluorothiazinon inhibits the virulence factors of uropathogenic Escherichia coli involved in the development of urinary tract infectionThe Journal of Antibiotics, 2023
- The Vibrio Polar Flagellum: Structure and Regulation2023
- Preventative treatment with Fluorothiazinon suppressed Acinetobacter baumannii-associated septicemia in miceThe Journal of Antibiotics, 2022
- Fluorothiazinon, a small-molecular inhibitor of T3SS, suppresses salmonella oral infection in miceThe Journal of Antibiotics, 2021
- Motility of Vibrio spp.: regulation and controlling strategiesApplied Microbiology and Biotechnology, 2020
- Coordinating assembly of a bacterial macromolecular machineNature Reviews Microbiology, 2008